Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines

British Journal of Surgery

Volumn 97, Issue 9, 2010, Pages 1385-1394

  Dai, M H ^a,b   Zamarin, D ^b   Gao, S P ^b   Chou, T C ^b   Gonzalez, L ^b   Lin, S F ^b   Fong, Y ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DIAGNOSTIC AGENT; DNA NUCLEOTIDYLEXOTRANSFERASE; PROPIDIUM IODIDE;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL SURVIVAL; GAMMA RADIATION; GENE THERAPY; GENE VECTOR; HERPES SIMPLEX VIRUS 1; HUMAN; METABOLISM; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NICK END LABELING; PANCREAS TUMOR; PATHOLOGY; RADIATION EXPOSURE; SIMPLEXVIRUS; TUMOR CELL CULTURE; VIRUS REPLICATION;

ADENOCARCINOMA; APOPTOSIS; CELL SURVIVAL; COLORING AGENTS; COMBINED MODALITY THERAPY; DNA NUCLEOTIDYLEXOTRANSFERASE; GAMMA RAYS; GENE THERAPY; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; IN SITU NICK-END LABELING; PANCREATIC NEOPLASMS; PROPIDIUM; SIMPLEXVIRUS; TUMOR CELLS, CULTURED; VIRUS REPLICATION;

EID: 77956420469     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7124     Document Type: Article

References (33)

1. Parkin DM, Pisani P, FerlayJ. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827-841.
2. Fernandez E, La VC, Porta. M, Negri E, Lucchini F, Levi F. Trends in pancreatic cancer mortality in Europe, 1.955-1989. Int J Cancer 1994; 57: 786-792.
3. Kitano M, Kudo M, Maekawa K, Suetomi Y, Sakamoto H, Fukuta N et al. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gat 2004; 53: 854-859.
4. Timmerman RD, Bizekis CS, Pass HI, Fong Y, Dupuy DE, Dawson LA et al. Local surgical, ablative, and radiation treatment of metastases. CA Cancer J Clin 2009; 59: 145-170.
5. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Hruban RH et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience, Ann Surg 1997; 225: 621-633.
6. White RR, Xie HB, Gottfried MR, Czito BG, Hurwitz HI, Morse MA et al. Significance of histological, response to preoperative chemoradiodierapy for pancreatic cancer. Ann Surg Oncol 2005; 12: 214-221.
7. Brown KM, Siripurapu V, Davidson M, Cohen SJ, Konski A, Watson JC et al. Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma. Am J Surg 2008; 195: 318-321.
8. Springen GM, Hoffe SE. Borderline resectable pancreatic cancer: on the edge of survival. Cancer Control 2008; 15: 295-307.
9. Regine WF, Abrams RA. Adjuvant therapy for pancreatic cancer: back to the future. IntJ Radiat Oncol Biol Phys 1998; 42: 59-63.
10. 18F]FEAU PET. PLoS One 2009; 4: e4789.
11. Adusumilli PS, Stiles BM, Chan MK, Mullerad M, Eisenberg DP, Ben-Porat L et al. Imaging and therapy of malignant pleural mesothelioma, using replication-competent herpes simplex viruses. J Gene Med 2006; 8: 603-615.
12. Yu Z, Adusumilli PS, Eisenberg DP, Darr E, Ghossein RA, Li S et al. Nectin-1 expression by squamous cell carcinoma is a predictor of herpes oncolytic sensitivity. Mol Ther 2007; 15: 103-113.
13. Kelly K, Brader P, Rein A, Shah JP, Wong RJ, Fong Y et al. Attenuated multimutated herpes simplex virus-1 effectively treats prostate carcinomas with neural, invasion while preserving nerve function. FASEB J 2008; 22: 1839-1848.
14. Fong Y, Kim. T, Bhargava A, Schwartz L, Brown K, Brody L et al. A herpes oncolytic virus can be delivered via me vasculature to produce biologic changes in human colorectal cancer. Mol Ther 2008; 17: 389-394.
15. Kim SH, Wong RJ, Kooby DA, Carew JF, Adusumilli PS, Patel SG et al. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma, of the head and neck. Eur J Cancer 2005;41:313-322.
16. Jarnagin WR, Zager JS, Hezel M, Stanziale SF, Adusumilli PS, Gonen M et al. Treatment of cholangiocarcinoma with oncolytic herpes simplex virus combined with external beam radiation therapy. Cancer Gene Ther 2006; 13: 326-334.
17. Blank SV, Rubin SC, Coukos G, Amin KM, Albelda SM, Molnar-Kimber KL. Replication-selective herpes simplex virus type 1 mutant therapy of cervical, cancer is enhanced by low-dose radiation. Hum Gene Ther 2002; 13: 627-639.
18. Advani SJ, Sibley GS, Song PY, Hallahan DE, Kataoka Y, Roizman B et al. Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a. new paradigm for destruction of therapeutically intractable tumors. Gene Ther 1998; 5: 160-165.
19. Adusumilli PS, Stiles BM, Chan MK, Chou TC, Wong RJ, Rusch VW et al. Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer. Ann Thome Surg 2005; 80: 409-416.
20. Chung SM, Advani SJ, Bradley JD, Kataoka Y, Vashistha K, Yan SY et al. The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma. Gene Ther 2002; 9: 75-80.
21. Adusumilli PS, Chan MK, Hezel M, Yu Z, Stiles BM, Chou TC et al. Radiation-induced cellular DNA damage repair response enhances viral gene therapy efficacy in the treatment of malignant pleural mesothelioma. Ann Surg Oncol2007; 14: 258-269.
22. Mezhir JJ, Advani SJ, Smith KD, Darga TE, Poon AP, Schmidt H et al. Ionizing radiation activates late herpes simplex virus 1 promoters via the p3 8 padiway in tumors treated with oncolytic viruses. Cancer Res 2005; 65: 9479-9484.
23. Wong RJ, Joe JK, Kim SH, Shah JP, Horsburgh B, Fong Y. Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther 2002; 13: 1213-1223.
24. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzym.c Regul 1984; 22: 27-55.
25. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58: 621-681.
26. Bracey TS, Miller JC, Preece A, Paraskeva C. Gamma-radiation-induced apoptosis in human colorectal adenoma and carcinoma, cell lines can occur in the absence of wild type p53. Oncogene 1995; 10: 2391-2396.
27. Needham PR, Midial NP, Hoskin PJ. Radiodierapy for bone pain. J R Soc Med 1994; 87: 503-505.
28. Serizawa T, Higuchi Y, Ono J, Matsuda S, Nagano O, Iwadate Y et al. Gamma knife surgery for metastatic brain tumors without prophylactic whole-brain radiotherapy: results in 1000 consecutive cases. J Neurosurg 2006; 105(Suppl): 86-90.
29. Wayne JD, Abdalla EK, Wolff RA, Crane CH, Pisters PW, Evans DB. Localized adenocarcinoma, of the pancreas: the rationale for preoperative chemoradiation. Oncologist 2002; 7: 34-45.
30. Conlon KC, Klimstra. DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. CIinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273-279.
31. Schneider G, Schmid RM. Genetic alterations in pancreatic carcinoma. Mol Cancer 2003; 2: 15.
32. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K. Signal transduction and cellular radiation responses. Radiât Res 2000; 153: 245-257.
33. Eisenberg DP, Adusumilli PS, Hendershott KJ, Yu Z, Mullerad M, Chan MK et al. 5-Fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in die treatment of pancreatic cancer. J Gastrointest Surg 2005;9:1068-1077.